Prevalence of cardiovascular risk factors and cardiovascular prevention quality in primary healthcare in Russia and European countries: EURIKA Study results

Por S. A. Boytsov
Publicado em 2012-02-01

ASCOT study: consequences and lessons

Por S. A. Boytsov
Publicado em 2007-12-01

ADDRESS TO THE READERS

Por S. A. Boytsov
Publicado em 2015-06-01

Applying Stochastic Metaheuristics to the Problem of Data Management in a Multi-Tenant Database Cluster

Por E. A. Boytsov
Publicado em 2014-08-01

Designing and Development of an Imitation Model of a Multi-Tenant Database Cluster

Por E. A. Boytsov
Publicado em 2013-08-01

PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY

Por S. A. Boytsov, I. P. Kolos
Publicado em 2016-01-01

From combined therapy to fixed-dose combinations

Por I. P. Kolos, S. A. Boytsov
Publicado em 2008-08-01

ENDOTHELIAL GLYCOCALYX — POTENTIAL VASCULAR BIOMARKER: DIAGNOSTIC AND THERAPEUTIC TARGET IN CARDIOVASCULAR DISEASES

Por A. Yu. Gorshkov, S. A. Boytsov
Publicado em 2015-12-01

CENTRALISED SURVEY ON THE UNDERTREATMENT OF THE HYPERCHOLESTEROLEMIA IN RUSSIA (CEPHEUS)

Por S. A. Boytsov, Yu. V. Khomitskaya
Publicado em 2013-08-01

SUBSEQUENT MYOCARDIAL INFARCTION: RISK ASSESSMENT AND PREVENTION

Por I. V. Samorodskaya, S. A. Boytsov
Publicado em 2017-07-01

DO FATS OR CARBOHYDRATES SHORTEN OUR LIVES? WHAT DOES THE PURE STUDY REVEAL?

Por A. E. Demkina, S. A. Boytsov
Publicado em 2018-07-01

From preventive cardiology to non-communicable disease prevention in Russia

Por S. A. Boytsov, R. G. Oganov
Publicado em 2013-08-01

Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II)

Por Boytsov, Sergey, Logunova, Natalia, Khomitskaya, Yunona
Publicado no Cardiovasc Diabetol (2017)

DYNAMICS IN MEDICAL TREATMENT OF ISCHEMIC HEART DISEASE IN CLINICAL PRACTICE

Por S. A. Shalnova, A. D. Deev, S. A. Boytsov
Publicado em 2015-09-01

Mortality and risk factors for non-communicable diseases in Russia: Specific features, trends, and prognosis

Por S A Boytsov, A D Deev, S A Shalnova
Publicado em 2017-01-01

Fighting with obesity: the "gold standard" and new horizons

Por O. M. Drapkina, Yu. V. Dubolazova, S. A. Boytsov
Publicado em 2016-09-01

The TRIPOD Statement: how to present the results of diagnostic and prognostic studies

Por I. P. Kolos, D. A. Anichkov, S. A. Boytsov
Publicado em 2015-12-01

GUT MICROBIOTA AND CARDIOVASCULAR RISK FACTORS. PART 1. GUT MICROBIOTA, AGE AND SEX

Por D. A. Kashtanova, O. N. Tkacheva, S. A. Boytsov
Publicado em 2015-08-01

GUT ENTEROBIOTA — A NEW PLAYER IN ATHEROSCLEROSIS PATHOGENESIS

Por L. V. Egshatyan, O. N. Tkacheva, S. A. Boytsov
Publicado em 2014-12-01

CURRENT ISSUES OF OBESITY CLASSIFICATION

Por I. V. Samorodskaya, E. V. Bolotova, S. A. Boytsov
Publicado em 2015-08-01